scribed by your healthcare provider (the amount of liquid medicine in Step 4). If you see air bubbles in the oral syringe, fully push in the plunger so that the oral solution flows back into the bottle. Then, withdraw your prescribed dose
of oral suspension.See Figure G
Measure the mLs of medicine from the white layer at the end of the plunger, not the black layer.
Step 7. If the dose is more than 20 mL, you can use:
2 syringes
or
1 syringe, taking 2 steps to draw up the medicine in that same syringe
For example:
If your dose is 24 mL, draw up 20 mL in the first syringe and the remaining 4 mL in the second syringe.
or
If your dose is 24 mL, draw up 20 mL in the single syringe and squirt the medicine into your mouth, then draw up the remaining 4 mL in that same syringe.
“If your dose is more than 20 mL, repeat Steps 4 through 6 when drawing up the remaining dose of medicine.”
Step 8. Turn the bottle right-side up and remove the syringe from the bottle adapter. See Figure H
Step 9. Slowly squirt the FYCOMPA oral suspension directly into the corner of your mouth until all of the liquid medicine is given. If you need 2 syringes for your dose, slowly squirt the medicine from the first syringe into your mouth, then slowly squirt the medicine from the second syringe into your mouth. See Figure I
Step 10. Rinse the syringe (or syringes) with tap water after each ue. See Figure J
Fill a cup with water
Pull back on the plunger and draw the water from the cup into the syringe
Push down on the plunger to release the water into the sink
Step 11. Cap the bottle tightly. The cap will fit over the bottle adapter. See Figure K
How should I store FYCOMPA Oral Suspension?
Store FYCOMPA oral suspension below 86°F (30°C). Do not freeze.
Replace the cap tightly after opening.
Use FYCOMPA oral suspension within 90 days after the bottle is first opened.
After 90 days safely throw away any FYCOMPA Oral Suspension that has not been used.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
FYCOMPA is a registered trademark owned by Eisai R&D Management Co., Ltd.
Marketed by Eisai Inc., Woodcliff Lake, NJ 07677
©2016 Eisai Inc.
Approved: April 2016
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 2 mg Tablet
NDC 62856-272-90
90 tablets
Rx only
Fycompa™
(perampanel)
tablets
CIII
2 mg
ATTENTION PHARMACIST:
Dispense the accompanying
Medication Guide to each patient.
Close
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 4 mg Tablet
NDC 62856-274-90
90 tablets
Rx only
Fycompa™
(perampanel)
tablets
CIII
4 mg
ATTENTION PHARMACIST:
Dispense the accompanying
Medication Guide to each patient.
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 6 mg Tablet
NDC 62856-276-90
90 tablets
Rx only
Fycompa™
(perampanel)
tablets
CIII
6 mg
ATTENTION PHARMACIST:
Dispense the accompanying
Medication Guide to each patient.
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 8 mg Tablet
NDC 62856-278-90
90 tablets
Rx only
Fycompa™
(perampanel)
tablets
CIII
8 mg
ATTENTION PHARMACIST:
Dispense the accompanying
Medication Guide to each patient
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 10 mg Tablet
NDC 62856-280-90
90 tablets
Rx only
Fycompa™
(perampanel)
tablets
CIII
10 mg
ATTENTION PHARMACIST:
Dispense the accompanying
Medication Guide to each patient.
PRINCIPAL DISPLAY PA |
